Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	GSK1838262 600 mg	126
Overall Study	STARTED	GSK1838262 450 mg	125
Overall Study	STARTED	GSK1838262 300 mg	125
Overall Study	STARTED	GSK1838262 Placebo Match	125
Overall Study	COMPLETED	GSK1838262 600 mg	95
Overall Study	COMPLETED	GSK1838262 450 mg	99
Overall Study	COMPLETED	GSK1838262 300 mg	94
Overall Study	COMPLETED	GSK1838262 Placebo Match	102
Overall Study	NOT COMPLETED	GSK1838262 600 mg	31
Overall Study	NOT COMPLETED	GSK1838262 450 mg	26
Overall Study	NOT COMPLETED	GSK1838262 300 mg	31
Overall Study	NOT COMPLETED	GSK1838262 Placebo Match	23

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01668667/flow